{"product_id":"thymosin-alpha-110mg","title":"Thymosin Alpha 110mg","description":"\u003cdiv class=\"whitespace-pre-wrap\"\u003e\u003cstrong\u003eFOR RESEARCH PURPOSES ONLY\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv class=\"whitespace-pre-wrap\"\u003e\n\u003cstrong\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"whitespace-pre-wrap\"\u003e\u003cstrong\u003e\u003cspan\u003eThis substance is not classified as a medication or a consumable product and should only be handled by properly qualified personnel in a controlled laboratory environment. Any information supplied about the product is intended strictly for educational purposes.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv class=\"whitespace-pre-wrap\"\u003e\n\u003cstrong\u003e\u003c\/strong\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"whitespace-pre-wrap\"\u003e\n\u003cspan class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"\u003e\u003cspan class=\"whitespace-normal\"\u003eThymosin alpha-1\u003c\/span\u003e\u003c\/span\u003e is an endogenous peptide fragment that was first identified in 1972. Following its discovery, it has been extensively evaluated in clinical studies involving numerous conditions, including cystic fibrosis, infectious diseases such as tuberculosis and cytomegalovirus, respiratory disorders, chronic hepatitis, and cancer. It has also been approved for the treatment of chronic hepatitis B and C in 35 developing countries.\u003c\/div\u003e","brand":"AMO Peptides","offers":[{"title":"Default Title","offer_id":56945333797247,"sku":null,"price":37.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/7411\/8015\/files\/Thymosin.png?v=1771520327","url":"https:\/\/amopeptides.com\/products\/thymosin-alpha-110mg","provider":"AMO Peptides","version":"1.0","type":"link"}